PST-2744
|
|
- CAS号:
- 203737-93-3
- 英文名:
- Istaroxime
- 英文别名:
- CS-1089;PST2744;PST 2744;PST-2744;Debio0614;Debio 0614;Istaroxime;PST2744/PST-2744;Istaroxime(PST2744);PST2744; PST 2744; ISTAROXIME; DEBIO 0614; DEBIO0614
- 中文名:
- PST-2744
- 中文别名:
- 化合物 T15600
- CBNumber:
- CB71508601
- 分子式:
- C21H32N2O3
- 分子量:
- 360.5
- MOL File:
- 203737-93-3.mol
|
|
|
PST-2744化学性质
-
沸点:
-
511.1±60.0 °C(Predicted)
-
|
-
密度:
-
1.34±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in H2O
-
|
-
形态:
-
Powder
-
|
-
酸度系数(pKa):
-
9.49±0.10(Predicted)
-
|
PST-2744性质、用途与生产工艺
Istaroxime (PST2744) 是一种有效的 Na+,K+-ATPase 抑制剂,IC50 值为 0.11 μM。
IC50: 0.11 μM (Na
+
,K
+
-ATPase)
Istaroxime acting as a positive inotropic compound through the inhibition of the Na
+
,K
+
-ATPase. Istaroxime (PST2744) inhibits the Na
+
/K
+
-ATPase activity from dog kidney with an IC
50
value of 0.43 ± 0.15 μM. Inhibition of Na
+
/K
+
-ATPase activity in preparations from guinea pig kidney yielded potencies of 8.5 μM for PST2744.
Istaroxime (PST2744) induces a progressive increase in +dP/dt
max
throughout the infusion that reaches 80% (ED
80
) at the cumulative dose of 1.89±0.37 mg/kg and a peak of 140±3.5% at the dose (ED
max
) of 4.88±0.6 mg/kg.
PST-2744
上下游产品信息
上游原料
下游产品
203737-93-3, PST-2744 相关搜索:
- 贝尔卡主打
- 医药原料
- 膜转运
- 离子通道
- 膜转运/离子通道
- 化合物 T15600
- 203737-93-3
- Androstane-3,6,17-trione, 3-[O-(2-aminoethyl)oxime], (5α)-
- Androstane-3,6,17-trione, 3-[O-(2-aminoethyl)oxime], (5α)-
- PST2744; PST 2744; ISTAROXIME; DEBIO 0614; DEBIO0614
- Debio0614
- Debio 0614
- (3E,5S,8R,9S,10R,13S,14S)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione
- Istaroxime(PST2744)
- CS-1089
- PST2744/PST-2744
- PST-2744
- PST2744
- PST 2744
- Istaroxime